Andrew Cittadine - 22 May 2024 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Chief Operating Officer
Signature
/s/ Kim R Tsuchimoto, Attorney-in-fact
Issuer symbol
MNPR
Transactions as of
22 May 2024
Net transactions value
$0
Form type
4
Filing time
24 May 2024, 16:59:02 UTC
Previous filing
02 Apr 2024
Next filing
31 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Stock Options Award $0 +25,000 $0.000000 25,000 22 May 2024 Common Stock 25,000 $0.6146 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest 6/48ths on November 21, 2024 and 1/48th per month thereafter.